Publications by authors named "M Chedid"
Background: Hepatocellular carcinoma (HCC) is an aggressive malignant neoplasm that requires liver transplantation (LT). Despite patients with HCC being prioritized by most organ allocation systems worldwide, they still have to wait for long periods. Locoregional therapies (LRTs) are employed as bridging therapies in patients with HCC awaiting LT.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to analyze how negative social and behavioral factors (SBDH) affect health care usage among heart failure patients at a safety-net community hospital.
- Out of 4,594 heart failure patients analyzed, 21% faced at least one adverse social or behavioral determinant, with a notable demographic skew towards younger Black males on Medicaid.
- Those with adverse SBDH experienced higher rates of hospitalizations and emergency department visits, indicating that these factors are linked to increased healthcare usage and serve as independent predictors for hospital readmissions.
Background: Tolvaptan is the only US Food and Drug Administration-approved drug to slow the progression of autosomal dominant polycystic kidney disease (ADPKD), but it requires strict clinical monitoring due to potential serious adverse events.
Objective: We aimed to share our experience in developing and implementing an electronic health record (EHR)-based application to monitor patients with ADPKD who were initiated on tolvaptan.
Methods: The application was developed in collaboration with clinical informatics professionals based on our clinical protocol with frequent laboratory test monitoring to detect early drug-related toxicity.
Polymorphic ventricular tachycardia (PVT) and ventricular fibrillation (VF) are life-threatening complications of takotsubo syndrome (TTS). Data regarding risk factors for PVT/VF based on the TTS variant are lacking. This study aimed to identify demographic and clinical factors associated with PVT and VF in patients with TTS.
View Article and Find Full Text PDF